Comparison of non-insulin antidiabetic agents as an add-on drug to insulin therapy in type 2 diabetes: a network meta-analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-018-22443-1.pdf
Reference73 articles.
1. Chan, J. L. & Abrahamson, M. J. Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin. Mayo Clin Proc 78, 459–467, https://doi.org/10.4065/78.4.459 (2003).
2. Edelman, S. & Pettus, J. Challenges associated with insulin therapy in type 2 diabetes mellitus. Am J Med 127, S11–16, https://doi.org/10.1016/j.amjmed.2014.07.003 (2014).
3. Inzucchi, S. E. et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 38, 140–149, https://doi.org/10.2337/dc14-2441 (2015).
4. Garber, A. J. et al. Consensus Statement By The American Association of Clinical Endocrinologists And American College of Endocrinology On The Comprehensive Type 2 Diabetes Management Algorithm - 2017 Executive Summary. Endocr Pract 23, 207–238, https://doi.org/10.4158/ep161682.cs (2017).
5. Higgins, J. P. T. & Green, S. Cochrane handbook for Systematic Reviews of Interventions, www.cochrane-handbook.org .
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparison of GLP‐1 Receptor Agonists, SGLT‐2 Inhibitors, and DPP‐4 Inhibitors as an Add‐On Drug to Insulin Combined With Oral Hypoglycemic Drugs: Umbrella Review;Journal of Diabetes Research;2024-01
2. Antidiabetic activity of Tartary buckwheat protein-derived peptide AFYRW and its effects on protein glycosylation of pancreas in mice;Amino Acids;2023-06-21
3. Impact of Type 2 Diabetes Duration on the Efficacy and Safety of Add-on Lixisenatide in Asian Individuals Receiving Basal Insulin: A Pooled Analysis;Diabetes Therapy;2023-02-21
4. Evaluation of motor vehicle crashes between scooter riders and car drivers after diagnosis of type 2 diabetes in Taiwan;Injury;2022-12
5. Suspected adverse drug reactions of the type 2 antidiabetic drug class dipeptidyl‐peptidase IV inhibitors ( DPP4i ): Can polypharmacology help explain?;Pharmacology Research & Perspectives;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3